• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏多糖贮积症:婴儿和儿童的早期诊断迹象。

Mucopolysaccharidoses: early diagnostic signs in infants and children.

机构信息

Department of Pediatrics, Fondazione MBBM, San Gerardo Hospital, Monza, Italy.

Unit of Rare Diseases, Department of Pediatrics, Gaslini Institute, Genoa, Italy.

出版信息

Ital J Pediatr. 2018 Nov 16;44(Suppl 2):133. doi: 10.1186/s13052-018-0550-5.

DOI:10.1186/s13052-018-0550-5
PMID:30442162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6238260/
Abstract

Mucopolysaccharidoses (MPS) comprise a group of lysosomal disorders that are characterized by progressive, systemic clinical manifestations and a coarse phenotype. The different types, having clinical, biochemical, and genetic heterogeneity, share key clinical features in varying combinations, including joint and skeletal dysplasia, coarse facial features, corneal clouding, inguinal or abdominal hernias, recurrent upper respiratory tract infections, heart valve disease, carpal tunnel syndrome, and variable neurological involvement. In the severe forms, these features usually appear in the first months of life, but a correct diagnosis is often reached later when suggestive signs are manifest. All MPS types may have severe or attenuated presentations depending on the residual enzymatic activity of the patient. Based on data from the literature and from personal experience, here we underline the very early signs of the severe forms which should alert the paediatrician on their first appearance. A few early signs are typical of MPS (i.e. gibbus) while many are unspecific (hernias, upper airway infections, organomegaly, etc.), and finding the association of many unspecific signs might prompt the paediatrician to search for a common cause and to carefully look for other more specific signs (gibbus and other skeletal deformities, heart murmur). We stress the need to increase awareness of MPS among paediatricians and other specialists to shorten the still existing diagnostic delay. A timely diagnosis is mandatory for the commencement of treatment as soon as possible, when available, to possibly obtain better results.

摘要

黏多糖贮积症(MPS)是一组溶酶体贮积症,其特征为进行性、全身性临床表现和粗糙表型。不同类型具有临床、生化和遗传异质性,以不同组合共享关键临床特征,包括关节和骨骼发育不良、粗糙面容、角膜混浊、腹股沟或腹部疝、复发性上呼吸道感染、心脏瓣膜病、腕管综合征和可变的神经受累。在严重形式中,这些特征通常在生命的头几个月出现,但在出现提示性体征时,通常较晚才做出正确诊断。所有 MPS 类型都可能具有严重或减轻的表现,具体取决于患者残留的酶活性。根据文献数据和个人经验,我们在此强调严重形式的早期迹象,这些迹象应该在首次出现时引起儿科医生的警惕。少数早期迹象是 MPS 的典型表现(即脊柱后凸),而许多是不特异的(疝、上呼吸道感染、器官肿大等),发现许多不特异的体征可能促使儿科医生寻找共同的病因,并仔细寻找其他更特异的体征(脊柱后凸和其他骨骼畸形、心脏杂音)。我们强调需要提高儿科医生和其他专家对 MPS 的认识,以缩短目前仍然存在的诊断延迟。及时诊断对于尽早开始治疗至关重要,如果有治疗方法,可能会获得更好的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/779d8bd6f27f/13052_2018_550_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/a97a685eb6bc/13052_2018_550_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/f068c68ba710/13052_2018_550_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/85aa9bc8ae30/13052_2018_550_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/c2b5e4052ad5/13052_2018_550_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/779d8bd6f27f/13052_2018_550_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/a97a685eb6bc/13052_2018_550_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/f068c68ba710/13052_2018_550_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/85aa9bc8ae30/13052_2018_550_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/c2b5e4052ad5/13052_2018_550_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c9/6238260/779d8bd6f27f/13052_2018_550_Fig7_HTML.jpg

相似文献

1
Mucopolysaccharidoses: early diagnostic signs in infants and children.黏多糖贮积症:婴儿和儿童的早期诊断迹象。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):133. doi: 10.1186/s13052-018-0550-5.
2
ENT and mucopolysaccharidoses.耳鼻喉科学与黏多糖贮积症。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):127. doi: 10.1186/s13052-018-0555-0.
3
Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion.儿童生长障碍和关节运动范围受限应引起对黏多糖贮积症衰减形式的怀疑:专家意见。
Eur J Pediatr. 2019 Apr;178(4):593-603. doi: 10.1007/s00431-019-03330-x. Epub 2019 Feb 11.
4
Mucopolysaccharidoses.黏多糖贮积症。
Curr Rheumatol Rep. 2014 Jan;16(1):389. doi: 10.1007/s11926-013-0389-0.
5
Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.黏多糖贮积症患者眼科特征的诊断与治疗。
Br J Ophthalmol. 2011 May;95(5):613-9. doi: 10.1136/bjo.2010.179937. Epub 2010 Sep 18.
6
Ocular features in mucopolysaccharidosis: diagnosis and treatment.黏多糖贮积症的眼部特征:诊断与治疗。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):125. doi: 10.1186/s13052-018-0559-9.
7
Therapies for the bone in mucopolysaccharidoses.黏多糖贮积症的骨骼治疗方法。
Mol Genet Metab. 2015 Feb;114(2):94-109. doi: 10.1016/j.ymgme.2014.12.001. Epub 2014 Dec 9.
8
Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.61例黏多糖贮积症患者的耳鼻咽喉科表现
Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110137. doi: 10.1016/j.ijporl.2020.110137. Epub 2020 May 27.
9
Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses.临床提示对黏多糖贮积症的衰减形式的诊断。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):132. doi: 10.1186/s13052-018-0551-4.
10
Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.黏多糖贮积症心脏表现的早期诊断和管理:儿科和成人心脏病学家实用指南。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):122. doi: 10.1186/s13052-018-0560-3.

引用本文的文献

1
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I.新生儿基因疗法可有效预防I型黏多糖贮积症小鼠模型中的疾病表现。
Mol Ther Methods Clin Dev. 2025 Jul 30;33(3):101544. doi: 10.1016/j.omtm.2025.101544. eCollection 2025 Sep 11.
2
rhGALNS Enzyme Stability in Physiological Buffers: Implications for Sustained Release.rhGALNS酶在生理缓冲液中的稳定性:对缓释的影响。
Appl Biochem Biotechnol. 2025 May 24. doi: 10.1007/s12010-025-05266-5.
3
Efficacy of different treatment strategies in patients with mucopolysaccharidosis: a systematic review and network meta-analysis of randomized controlled trials.

本文引用的文献

1
Clinical hints to diagnosis of attenuated forms of Mucopolysaccharidoses.临床提示对黏多糖贮积症的衰减形式的诊断。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):132. doi: 10.1186/s13052-018-0551-4.
2
Newborn screening in mucopolysaccharidoses.黏多糖贮积症的新生儿筛查。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):126. doi: 10.1186/s13052-018-0552-3.
3
Epidemiology of mucopolysaccharidoses.黏多糖贮积症的流行病学
不同治疗策略对黏多糖贮积症患者的疗效:一项随机对照试验的系统评价和网状Meta分析
Orphanet J Rare Dis. 2025 May 2;20(1):211. doi: 10.1186/s13023-025-03735-y.
4
Pediatric Interventions in a Sanfilippo Syndrome Patient Under General Anesthesia: A Case Report.全身麻醉下对一名Sanfilippo综合征患者的儿科干预:病例报告
Case Rep Dent. 2025 Jan 6;2025:7892363. doi: 10.1155/crid/7892363. eCollection 2025.
5
The diagnosis and management of mucopolysaccharidosis type II.黏多糖贮积症 II 型的诊断与治疗。
Ital J Pediatr. 2024 Oct 8;50(1):207. doi: 10.1186/s13052-024-01769-9.
6
CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis.CRISPR/Cas9技术在黏多糖贮积症建模与治疗中的应用
Biochem Biophys Rep. 2024 Jul 1;39:101771. doi: 10.1016/j.bbrep.2024.101771. eCollection 2024 Sep.
7
Lung Diseases and Rare Disorders: Is It a Lysosomal Storage Disease? Differential Diagnosis, Pathogenetic Mechanisms and Management.肺部疾病与罕见病:它是一种溶酶体贮积症吗?鉴别诊断、发病机制与管理
Children (Basel). 2024 May 30;11(6):668. doi: 10.3390/children11060668.
8
Macrocephaly and Finger Changes: A Narrative Review.大头畸形和手指改变:一篇叙述性综述。
Int J Mol Sci. 2024 May 20;25(10):5567. doi: 10.3390/ijms25105567.
9
Morquio B disease: a case report.莫尔基奥B病:一例报告。
Front Pediatr. 2024 Mar 4;12:1285414. doi: 10.3389/fped.2024.1285414. eCollection 2024.
10
Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB.代谢重编程和自噬抑制纠正黏多糖贮积症IIIB中的溶酶体贮积病。
iScience. 2024 Jan 29;27(3):108959. doi: 10.1016/j.isci.2024.108959. eCollection 2024 Mar 15.
Mol Genet Metab. 2017 Jul;121(3):227-240. doi: 10.1016/j.ymgme.2017.05.016. Epub 2017 May 26.
4
Early disease progression of Hurler syndrome.黏多糖贮积症Ⅰ型的早期疾病进展
Orphanet J Rare Dis. 2017 Feb 14;12(1):32. doi: 10.1186/s13023-017-0583-7.
5
Newborn Screening for Lysosomal Storage Disorders.溶酶体贮积症的新生儿筛查
J Pediatr Genet. 2017 Mar;6(1):51-60. doi: 10.1055/s-0036-1593843. Epub 2016 Dec 2.
6
Lysosomal Storage Disorders in Nonimmune Hydrops Fetalis (NIHF): An Indian Experience.非免疫性胎儿水肿(NIHF)中的溶酶体贮积症:印度经验
JIMD Rep. 2017;35:47-52. doi: 10.1007/8904_2016_24. Epub 2016 Dec 8.
7
Clinical course of sly syndrome (mucopolysaccharidosis type VII).斯利综合征(黏多糖贮积症VII型)的临床病程。
J Med Genet. 2016 Jun;53(6):403-18. doi: 10.1136/jmedgenet-2015-103322. Epub 2016 Feb 23.
8
The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS).亨特综合征患者生长发育的自然史:来自亨特结局调查(HOS)的数据。
Mol Genet Metab. 2016 Apr;117(4):438-46. doi: 10.1016/j.ymgme.2016.01.009. Epub 2016 Jan 25.
9
International guidelines for the management and treatment of Morquio A syndrome.莫尔基奥A综合征管理与治疗的国际指南。
Am J Med Genet A. 2015 Jan;167A(1):11-25. doi: 10.1002/ajmg.a.36833. Epub 2014 Oct 24.
10
Mucopolysaccharidosis type II, Hunter's syndrome.II型黏多糖贮积症,亨特综合征。
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:107-13.